Search Results - "Yang, Jeff Y."

Burden and Cost of Outpatient Hemorrhoids in the United States Employer-Insured Population, 2014 by Yang, Jeff Y, Peery, Anne F, Lund, Jennifer L, Pate, Virginia, Sandler, Robert S

“…Although hemorrhoids are a common indication for seeking health care, there are no contemporary estimates of burden and cost. We examined data from an…”
Get full text

Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research by Yang, Jeff Y., Webster-Clark, Michael, Lund, Jennifer L., Sandler, Robert S., Dellon, Evan S., Stürmer, Til

“…Confounding is a major concern in nonexperimental studies of endoscopic interventions and can lead to biased estimates of the effects of treatment. Propensity…”
Get full text

Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting by Li, Dandan, Silvester, Jocelyn Anne, Crowley, Matthew J., Yang, Jeff Y., Alexopoulos, Anastasia-Stefania, Xu, Yang, Zhan, Siyan, Wang, Tiansheng

Get full text

Utilization of Colonoscopy Following Treatment Initiation in U.S. Commercially Insured Patients With Inflammatory Bowel Disease, 2013-2019 by Yang, Jeff Y, Lund, Jennifer L, Pate, Virginia, Kappelman, Michael D

“…Abstract Background Evaluation of mucosal healing with colonoscopy is recommended for inflammatory bowel disease (IBD) management; however, little is known…”
Get full text

Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century by Moon, Andrew M., Yang, Jeff Y., Barritt, A. Sidney, Bataller, Ramon, Peery, Anne F.

“…In contrast with other developed nations, life expectancy is decreasing in the United States, in part due to increasing mortality from alcohol-associated liver…”
Get full text

Utilization of Treat-to-Target Monitoring Colonoscopy after Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD) by Yang, Jeff Y., Lund, Jennifer L., Funk, Michele Jonsson, Hudgens, Michael G., Lewis, James D., Kappelman, Michael D.

“…Endoscopic healing has been associated with improved long-term clinical outcomes in inflammatory bowel disease (IBD) and is a recommended target for treatment…”
Get full text

Correction to: Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease by Yang, Jeff Y., Lund, Jennifer L., Funk, Michele Jonsson, Hudgens, Michael G., Lewis, James D., Kappelman, Michael D.

Get full text

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials by Li, Guangyao, Crowley, Matthew J, Tang, Huilin, Yang, Jeff Y, Sandler, Robert S, Wang, Tiansheng

Get full text

Leveraging auxiliary data to improve precision in inverse probability-weighted analyses by Zalla, Lauren C., Yang, Jeff Y., Edwards, Jessie K., Cole, Stephen R.

“…To demonstrate improvements in the precision of inverse probability-weighted estimators by use of auxiliary variables, i.e., determinants of the outcome that…”
Get full text

Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial by Brenner, Alison T., Rhode, Jewels, Yang, Jeff Y., Baker, Dana, Drechsel, Rebecca, Plescia, Marcus, Reuland, Daniel S., Wroth, Tom, Wheeler, Stephanie B.

“…Background Colorectal cancer (CRC) screening is effective but underused. Screening rates are lower among Medicaid beneficiaries versus other insured…”
Get full text

Sodium‐glucose co‐transporter‐2 inhibitor use and risk of lower‐extremity amputation: Evolving questions, evolving answers by Yang, Jeff Y., Wang, Tiansheng, Pate, Virginia, Gower, Emily W., Crowley, Matthew J., Buse, John B., Stürmer, Til

“…Aim To examine whether sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors are associated with a higher risk of lower‐extremity amputation than…”
Get full text

Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer by Shmuel, Shahar, Yang, Jeff Y., Thai, Sydney, Webster‐Clark, Michael, Lund, Jennifer L.

Get full text

Assessing the Association Between Dipeptidyl Peptidase 4 Inhibitor Use and Inflammatory Bowel Disease Through Drug Adverse Event Reporting by Wang, Tiansheng, Lu, Wenchao, Li, Dandan, Tang, Huilin, Yang, Jeff Y, Buse, John B, Stürmer, Til

Get full text

Comparative cost‐effectiveness of mailed fecal immunochemical testing (FIT)–based interventions for increasing colorectal cancer screening in the Medicaid population by Wheeler, Stephanie B., O’Leary, Meghan C., Rhode, Jewels, Yang, Jeff Y., Drechsel, Rebecca, Plescia, Marcus, Reuland, Daniel S., Brenner, Alison T.

“…Background Mailed reminders to promote colorectal cancer (CRC) screening by fecal immunochemical testing (FIT) have been shown to be effective in the Medicaid…”
Get full text

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults by Wang, Tiansheng, Yang, Jeff Y, Buse, John B, Pate, Virginia, Tang, Huilin, Barnes, Edward L, Sandler, Robert S, Stürmer, Til

“…A recent study raises concerns that dipeptidyl peptidase 4 inhibitors (DPP4i) are associated with increased risk of inflammatory bowel disease (IBD). We…”
Get full text

Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data by Tang, Huilin, Zhou, Liyuan, Li, Xiaotong, Kinlaw, Alan C., Yang, Jeff Y., Moon, Andrew M., Barnes, Edward L., Wang, Tiansheng

“…Background Liver injury has been documented independently in novel coronavirus disease 2019 (COVID-19) patients and patients treated with lopinavir-ritonavir …”
Get full text

Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes by Yang, Jeff Y., Moon, Andrew M., Kim, Hannah, Pate, Virginia, Barritt, A. Sidney, Crowley, Matthew J., Buse, John B., Stürmer, Til, Alexopoulos, Anastasia-Stefania

“…Type 2 diabetes (T2D) accelerates progression of chronic liver disease to cirrhosis, yet the effects of most glucose-lowering drugs (GLDs) on cirrhosis risk in…”
Get full text

858 UTILIZATION OF COLONOSCOPY FOLLOWING TREATMENT INITIATION IN COMMERCIALLY-INSURED US PATIENTS WITH INFLAMMATORY BOWEL DISEASE, 2013-2018 by Yang, Jeff Y., Lund, Jennifer L., Kappelman, Michael

Get full text

Assessing Clinical Trial Effects on Outcomes Among Pediatric and Adolescent and Young Adult (AYA) Cancer Patients by Shmuel, Shahar, Yang, Jeff Y., Thai, Sydney, Webster-Clark, Michael, Lund, Jennifer L.

Get full text

Su1015 - Cost-Utility of Screening for Renal Dysfunction to Detect the Onset and Progression of Chronic Kidney Disease Among Elderly Patients Treated with Proton-Pump Inhibitors by Yang, Jeff Y., Chang, Emily H., Wheeler, Stephanie, Dellon, Evan S.

Get full text